Schedule 13G ownership disclosure
SECOND SIGHT MEDICAL PRODUCT
Security class unavailable · CUSIP: 81362J100
Event date: 2020-05-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,200,000
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000092
- Form type
- SC 13G
- Filer
- SABBY MANAGEMENT, LLC
- CIK
- CIK 1535610
- Filed
- May 01, 2020
- Reporting period
- May 01, 2020
- Description
- Schedule 13G beneficial ownership